Acute transverse myelitis and antiphospholipid antibodies in lupus. No evidence for anticoagulation

European Journal of Neurology

Volumn 18, Issue 4, 2011, Pages 556-563

  Katsiari, C G ^a   Giavri, I ^b   Mitsikostas, D D ^b   Yiannopoulou, K G ^c   Sfikakis, P P ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ATHENS NAVAL HOSPITAL   (Greece)

^c LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Anticoagulation; Antiphospholipid antibodies; Systemic lupus erythematosus; Transverse myelitis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; HEPARIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHOLIPID ANTIBODY; STEROID; WARFARIN;

ACUTE TRANSVERSE MYELITIS; ADVERSE OUTCOME; ANTIBODY DETECTION; ANTICOAGULANT THERAPY; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CEREBROVASCULAR DISEASE; CERVICAL SPINE INJURY; CLINICAL FEATURE; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; EXPANDED DISABILITY STATUS SCALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MYELITIS; NEUROLOGIC DISEASE; NEUROPATHOLOGY; OPTIC NEURITIS; PARALYSIS; PRIORITY JOURNAL; PSYCHOSIS; RELAPSE; SEIZURE; STEROID THERAPY; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOGENESIS;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MYELITIS, TRANSVERSE; PROGNOSIS; THROMBOSIS;

EID: 79952716627     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03208.x     Document Type: Article

References (20)

1. Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 2000; 59: 120-124.
2. West SG. Lupus and the central nervous system. Curr Opin Rheumatol 1996; 8: 408-414.
3. Lavalle C, Pizarro S, Drenkard C, Sanchez-Guerrero J, Alarcon-Segovia D. Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J Rheumatol 1990; 17: 34-37.
4. Sanna G, Bertolaccini ML, Khamashta MA. Neuropsychiatric involvement in systemic lupus erythematosus: current therapeutic approach. Curr Pharm Des 2008; 14: 1261-1269.
5. Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002; 59:499-505.
6. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
7. Deodhar AA, Hochenedel T, Bennett RM. Longitudinal involvement of the spinal cord in a patient with lupus related transverse myelitis. J Rheumatol 1999; 26: 446-449.
8. Espinosa G, Mendizabal A, Minguez S et al. Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients. Semin Arthritis Rheum 2010; 39: 246-256.
9. Lu X, Gu Y, Wang Y, Chen S, Ye S. Prognostic factors of lupus myelopathy. Lupus 2008; 17: 323-328.
10. Boumpas DT, Patronas NJ, Dalakas MC, et al. Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literature. J Rheumatol 1990; 17: 89-92.
11. Alarcσn-Segovia D, Delezι M, Oria CV, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989; 68: 353-365.
12. Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1, 000 patients. Arthritis Rheum 2002; 46: 1019-1027.
13. Sanna G, Bertolaccini ML, Cuadrado MJ, et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003; 30: 985-992.
14. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
15. Kim JH, Lee SI, Park SI, Yoo WH. Recurrent transverse myelitis in primary antiphospholipid syndrome - case report and literature review. Rheumatol Int 2004; 24: 244-246.
16. Lehnhardt FG, Impekoven P, Rubbert A, et al. Recurrent longitudinal myelitis as primary manifestation of SLE. Neurology 2004; 63:1976.
17. Shaharao V, Bartakke S, Muranjan MN, et al. Recurrent acute transverse myelopathy: association with antiphospholipid antibody syndrome. Indian J Pediatr 2004; 71: 559-561.
18. Birnbaum J, Petri M, Thompson R, Izbudak I, Kerr D. Distinct subtypes of myelitis in systemic lupus erythematosus. Arthritis Rheum 2009; 60: 3378-3387.
19. Ingall TJ. Intravenous thrombolysis for acute ischemic stroke: time is prime. Stroke 2009; 40: 2264-2265.
20. Sherer Y, Hassin S, Shoenfeld Y, et al. Transverse myelitis in patients with antiphospholipid antibodies - the importance of early diagnosis and treatment. Clin Rheumatol 2002; 21: 207-210.